Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review.
Shen C, Dawe J, Traeger MW, Sacks-Davis R, Pedrana AE, Doyle JS, Hellard ME, Stoové M
Hepatitis C Injecting Drug Use
Risk of primary incident hepatitis C infection following bacterial sexually transmissible infections among gay and bisexual men in Australia from 2016 to 2020.
Harney BL, Sacks-Davis R, Agius P, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS
Global Infectious Disease Threats Hepatitis C
Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020.
Harney BL, Sacks-Davis R, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS
Global Infectious Disease Threats Hepatitis C HIV + AIDS
Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020.
Harney BL, Sacks-Davis R, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS.
Hepatitis C HIV + AIDS
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility.
MacIsaac MB, Whitton B, Anderson J, Cogger S, Vella-Horne D, Penn M, Weeks T, Elmore K, Pemberton D, Winter RJ, Papaluca T, Howell J, Hellard M, Stoové M, Wilson D, Pedrana A, Doyle JS, Clark N, Holmes JA, Thompson AJ.
Hepatitis C Injecting Drug Use
Characterizing Socioecological Markers of Differentiated HIV Risk Among Men Who Have Sex with Men in Indonesia.
Nevendorff L, Pedrana A, Bourne A, Traeger M, Sindunata E, Reswana WA, Alharbi RM, Stoové M.
Hepatitis C